Comprehensive Psychiatry
Volume 50, Issue 6 , Pages 517-525 , November 2009

Brief cognitive-behavioral therapy with fibromyalgia patients in routine care

  • Susana Vázquez-Rivera

      Affiliations

    • Instituto de Psiquiatría y Salud Mental, Hospital Universitario Clínico San Carlos, Madrid 28040, Spain
    • Corresponding Author InformationCorresponding author. Tel.: +34 91 330 3572; fax: +34 91 330 3574.
    • ,
  • César González-Blanch

      Affiliations

    • Centro de Salud Mental, Hospital Universitario “Marqués de Valdecilla”, Santander 39008, Spain
    • ,
  • Laura Rodríguez-Moya

      Affiliations

    • Instituto de Psiquiatría y Salud Mental, Hospital Universitario Clínico San Carlos, Madrid 28040, Spain
    • ,
  • Dolores Morón

      Affiliations

    • Instituto de Psiquiatría y Salud Mental, Hospital Universitario Clínico San Carlos, Madrid 28040, Spain
    • ,
  • Sara González-Vives

      Affiliations

    • Instituto de Psiquiatría y Salud Mental, Hospital Universitario Clínico San Carlos, Madrid 28040, Spain
    • ,
  • José Luis Carrasco

      Affiliations

    • Instituto de Psiquiatría y Salud Mental, Hospital Universitario Clínico San Carlos, Madrid 28040, Spain
    • Centro de Investigación Biomédica en Red de Salud Mental, CIBERSAM, Madrid 28040, Spain

References 

  1. Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum. 1990;33:160–172
  2. Verbunt JA, Pernot DH, Smeets RJ. Disability and quality of life in patients with fibromyalgia. Health Qual Life Outcomes. 2008;6:8
  3. Berger A, Dukes E, Martin S, Edelsberg J, Oster G. Characteristics and healthcare costs of patients with fibromyalgia syndrome. Int J Clin Pract. 2007;61:1498–1508
  4. White LA, Birnbaum HG, Kaltenboeck A, Tang J, Mallett D, Robinson RL. Employees with fibromyalgia: medical comorbidity, healthcare costs, and work loss. J Occup Environ Med. 2008;50:13–24
  5. Fietta P, Manganelli P. Fibromyalgia and psychiatric disorders. Acta Biomed. 2007;78:88–95
  6. Sarzi-Puttini P, Buskila D, Carrabba M, Doria A, Atzeni F. Treatment strategy in fibromyalgia syndrome: where are we now?. Semin Arthritis Rheum. 2007;
  7. Forseth KK, Gran JT. Management of fibromyalgia: what are the best treatment choices?. Drugs. 2002;62:577–592
  8. Williams DA. Psychological and behavioural therapies in fibromyalgia and related syndromes. Best Pract Res Clin Rheumatol. 2003;17:649–665
  9. Bergman S. Management of musculoskeletal pain. Best Pract Res Clin Rheumatol. 2007;21:153–166
  10. Goldenberg DL, Burckhardt C, Crofford L. Management of fibromyalgia syndrome. JAMA. 2004;292:2388–2395
  11. Rossy LA, Buckelew SP, Dorr N, Hagglund KJ, Thayer JF, McIntosh MJ, et al. A meta-analysis of fibromyalgia treatment interventions. Ann Behav Med. 1999;21:180–191
  12. Garcia J, Simon MA, Duran M, Canceller J, Aneiros FJ. Differential efficacy of a cognitive-behavioral intervention versus pharmacological treatment in the management of fibromyalgic syndrome. Psychol Health Med. 2006;11:498–506
  13. Kurtais Y, Kutlay S, Ergin S. Exercise and cognitive-behavioural treatment in fibromyalgia syndrome. Curr Pharm Des. 2006;12:37–45
  14. Sim J, Adams N. Systematic review of randomized controlled trials of nonpharmacological interventions for fibromyalgia. Clin J Pain. 2002;18:324–336
  15. Pastor MA, Pons N, Lledó A, Martín-Aragón M, López-Roig S, Terol MC, et al. Guía de tratamientos psicológicos eficaces en las enfermedades reumáticas: el caso de la fibromialgia. In:  Pérez M,  Fernández JR,  Fernández C,  Amigo I editor. Guía de tratamientos psicológicos eficaces II Psicología de la salud. Madrid: Ed. Pirámide; 2003;p. 157–168
  16. Williams DA, Cary MA, Groner KH, Chaplin W, Glazer LJ, Rodriguez AM, et al. Improving physical functional status in patients with fibromyalgia: a brief cognitive behavioral intervention. J Rheumatol. 2002;29:1280–1286
  17. Bennett R, Nelson D. Cognitive behavioral therapy for fibromyalgia. Nat Clin Pract Rheumatol. 2006;2:416–424
  18. Austin SF, Sumbundu AD, Lykke J, Oestrich IH. Treating panic symptoms within everyday clinical settings: the feasibility of a group cognitive behavioural intervention. Nord J Psychiatry. 2008;62:287–293
  19. Eccleston C, Crombez G. Pain demands attention: a cognitive-affective model of the interruptive function of pain. Psychol Bull. 1999;125:356–366
  20. Turk DC, Sherman JJ. Treatment of patients with fibromyalgia syndrome. In:  Turk DC,  Gatchel RJ editor. Psychological approaches to pain management. A practitioner's handbook. New York: The Guilford Press; 2002;p. 390–416
  21. Morley S, Shapiro DA, Biggs J. Developing a treatment manual for attention management in chronic pain. Cogn Behav Ther. 2004;33:1–11
  22. Sanz J, Vázquez C. Fiabilidad, validez y datos normativos del Inventario para la Depresión de Beck. Psicothema. 1998;10:303–318
  23. Infante Vargas P. Estudio de variables psicológicas en pacientes con dolor crónico. Departament de Psicología de la Salut i Psicología Social. Barcelona: Universitat Autónoma de Barcelona; 2002;
  24. Seisdedos N. STAI. Cuestionario de Ansiedad Estado-Rasgo. Madrid: TEA Ediciones; 1994;
  25. Soriano J, Monsalve V. CAD: Cuestionario de Afrontamiento ante el Dolor Crónico. Rev Soc Esp Dolor. 2002;13–22
  26. Burckhardt CS, Clark SR, Bennett RM. The fibromyalgia impact questionnaire: development and validation. J Rheumatol. 1991;18:728–733
  27. de Gracia M, Marcó M, Ruiz J, Garabieta F. Evaluación de los aspectos psicológicos de la fibromialgia. Análisis y Modificación de Conducta. 2001;27:959–980
  28. Redondo JR, Justo CM, Moraleda FV, Velayos YG, Puche JJ, Zubero JR, et al. Long-term efficacy of therapy in patients with fibromyalgia: a physical exercise-based program and a cognitive-behavioral approach. Arthritis Rheum. 2004;51:184–192
  29. Turk DC, Okifuji A, Sinclair JD, Starz TW. Interdisciplinary treatment for fibromyalgia syndrome: clinical and statistical significance. Arthritis Care Res. 1998;11:186–195
  30. Noyes R, Langbehn DR, Happel RL, Sieren LR, Muller BA. Health Attitude Survey. A scale for assessing somatizing patients. Psychosomatics. 1999;40:470–478
  31. Kirmayer LJ, Robbins JM, Kapusta MA. Somatization and depression in fibromyalgia syndrome. Am J Psychiatry. 1988;145:950–954
  32. Hochberg Y, Benjamini Y. More powerful procedures for multiple significance testing. Stat Med. 1990;9:811–818
  33. Merikangas KR, Kalaydjian A. Magnitude and impact of comorbidity of mental disorders from epidemiologic surveys. Curr Opin Psychiatry. 2007;20:353–358
  34. Sartorius N, Ustun TB, Lecrubier Y, Wittchen HU. Depression comorbid with anxiety: results from the WHO study on psychological disorders in primary health care. Br J Psychiatry Suppl. 1996;38–43
  35. McGlinchey JB, Zimmerman M. Examining a dimensional representation of depression and anxiety disorders' comorbidity in psychiatric outpatients with item response modeling. J Abnorm Psychol. 2007;116:464–474
  36. Katon W, Lin EH, Kroenke K. The association of depression and anxiety with medical symptom burden in patients with chronic medical illness. Gen Hosp Psychiatry. 2007;29:147–155
  37. Smedstad LM, Vaglum P, Moum T, Kvien TK. The relationship between psychological distress and traditional clinical variables: a 2 year prospective study of 216 patients with early rheumatoid arthritis. Br J Rheumatol. 1997;36:1304–1311
  38. Epstein SA, Kay G, Clauw D, Heaton R, Klein D, Krupp L, et al. Psychiatric disorders in patients with fibromyalgia. A multicenter investigation. Psychosomatics. 1999;40:57–63
  39. Hassett AL, Cone JD, Patella SJ, Sigal LH. The role of catastrophizing in the pain and depression of women with fibromyalgia syndrome. Arthritis Rheum. 2000;43:2493–2500
  40. Creamer P, Singh BB, Hochberg MC, Berman BM. Sustained improvement produced by nonpharmacologic intervention in fibromyalgia: results of a pilot study. Arthritis Care Res. 2000;13:198–204
  41. Bair MJ, Robinson RL, Katon W, Kroenke K. Depression and pain comorbidity: a literature review. Arch Intern Med. 2003;163:2433–2445
  42. Katon WJ. Clinical and health services relationships between major depression, depressive symptoms, and general medical illness. Biol Psychiatry. 2003;54:216–226
  43. Rhudy JL, Meagher MW. The role of emotion in pain modulation. Curr Opin Psychiatry. 2001;14:241–245
  44. Zelman DC, Howland EW, Nichols SN, Cleeland CS. The effects of induced mood on laboratory pain. Pain. 1991;46:105–111
  45. Pressman SD, Cohen S. Does positive affect influence health?. Psychol Bull. 2005;131:925–971
  46. Sandstrom MJ, Keefe FJ. Self-management of fibromyalgia: the role of formal coping skills training and physical exercise training programs. Arthritis Care Res. 1998;11:432–447
  47. Eccleston C. Chronic pain and distraction: an experimental investigation into the role of sustained and shifting attention in the processing of chronic persistent pain. Behav Res Ther. 1995;33:391–405
  48. Goubert L, Crombez G, Eccleston C, Devulder J. Distraction from chronic pain during a pain-inducing activity is associated with greater post-activity pain. Pain. 2004;110:220–227
  49. Thieme K, Flor H, Turk DC. Psychological pain treatment in fibromyalgia syndrome: efficacy of operant behavioural and cognitive behavioural treatments. Arthritis Res Ther. 2006;8:R121
  50. Nielson WR, Jensen MP. Relationship between changes in coping and treatment outcome in patients with fibromyalgia syndrome. Pain. 2004;109:233–241
  51. Kashikar-Zuck S, Swain NF, Jones BA, Graham TB. Efficacy of cognitive-behavioral intervention for juvenile primary fibromyalgia syndrome. J Rheumatol. 2005;32:1594–1602
  52. Eccleston C. The attentional control of pain: methodological and theoretical concerns. Pain. 1995;63:3–10
  53. Grossman P, Niemann L, Schmidt S, Walach H. Mindfulness-based stress reduction and health benefits. A meta-analysis. J Psychosom Res. 2004;57:35–43
  54. Sephton SE, Salmon P, Weissbecker I, Ulmer C, Floyd A, Hoover K, et al. Mindfulness meditation alleviates depressive symptoms in women with fibromyalgia: results of a randomized clinical trial. Arthritis Rheum. 2007;57:77–85
  55. Grossman P, Tiefenthaler-Gilmer U, Raysz A, Kesper U. Mindfulness training as an intervention for fibromyalgia: evidence of postintervention and 3-year follow-up benefits in well-being. Psychother Psychosom. 2007;76:226–233
  56. Mease P, Arnold LM, Bennett R, Boonen A, Buskila D, Carville S, et al. Fibromyalgia syndrome. J Rheumatol. 2007;34:1415–1425
  57. Russo J, Katon W, Sullivan M, Clark M, Buchwald D. Severity of somatization and its relationship to psychiatric disorders and personality. Psychosomatics. 1994;35:546–556
  58. Katon W, Lin E, Von Korff M, Russo J, Lipscomb P, Bush T. Somatization: a spectrum of severity. Am J Psychiatry. 1991;148:34–40

 The work was conducted at: Instituto de Psiquiatría y Salud Mental, Hospital Universitario Clínico San Carlos, Madrid, Spain.

PII: S0010-440X(09)00019-4

doi: 10.1016/j.comppsych.2009.01.008

Comprehensive Psychiatry
Volume 50, Issue 6 , Pages 517-525 , November 2009

Article Tools

* Image Usage & Resolution